MxA <scp>mRNA</scp> decrease preceding <scp>NA</scp>b detection in <scp>IFN</scp>β‐treated <scp>MS</scp> patients

Our data indicate that quantification of MxA mRNA is a more sensitive identifier of loss of IFNβ efficacy than the NAb positivity.